BIVI BIOVIE INC.
Nasdaq · SEC CIK 1580149 · EDGAR
- Bought, last 12 months
- $49.1K 4 purchases by 4 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 82 since 2021-09-16, latest 2026-08-28 21:01
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| DO CUONG V | Pres, CEO, Dir | $31.6K | — |
| Palumbo Joseph M | Chief Medical Off | $10.5K | — |
| KIM JOANNE WENDY | CFO | $5,450 | — |
| Chappell Amy Suzon | Dir | $1,570 | — |
Transactions 53
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-28 21:01 | 2026-08-28 | BIVI | Palumbo Joseph M | Chief Medical Off | P - Purchase | $2.16 | +4,843 | 6,036 | +406% | +$10.5K | |
| 2026-08-28 21:01 | 2026-08-28 | BIVI | Chappell Amy Suzon | Dir | P - Purchase | $2.16 | +727 | 727 | New | +$1,570 | |
| 2026-08-28 20:58 | 2026-08-28 | BIVI | KIM JOANNE WENDY | CFO | P - Purchase | $2.18 | +2,500 | 3,441 | +266% | +$5,450 | |
| 2026-08-28 20:57 | 2026-08-27 | BIVI | DO CUONG V | Pres, CEO, Dir | P - Purchase | $2.08 | +15.2K | 16.1K | +1,677% | +$31.6K | |
| DI | 2025-08-13 | 2025-08-07 | BIVI | DO CUONG V | Pres, CEO, Dir | P - Purchase | — | +5,000 | 9,992 | +100% | — |
| D | 2025-01-07 | 2024-11-20 | BIVI | BERMAN RICHARD J | Dir | A - Grant | $0.00 | +34.2K | 40.6K | +531% | $0 |
| D | 2025-01-07 | 2024-11-20 | BIVI | ROGICH SIGMUND | Dir | A - Grant | $0.00 | +32.7K | 36.9K | +774% | $0 |
| DM | 2024-07-12 | 2023-02-16+ | BIVI | Palumbo Joseph M | Chief Medical Off | F - Tax | $0.8893 | -34.0K | 32.2K | -51% | -$30.2K |
| D | 2024-07-12 | 2024-06-24 | BIVI | Palumbo Joseph M | Chief Medical Off | A - Grant | $0.00 | +116.0K | 148.2K | +360% | $0 |
| DMI | 2024-07-12 | 2023-02-16+ | BIVI | DO CUONG V | Pres, CEO, Dir | F - Tax | $1.02 | -51.9K | 551.9K | -9% | -$52.9K |
| DI | 2024-07-12 | 2024-06-24 | BIVI | DO CUONG V | Pres, CEO, Dir | A - Grant | $0.00 | +168.0K | 593.9K | +39% | $0 |
| DM | 2024-07-12 | 2023-02-16+ | BIVI | KIM JOANNE WENDY | CFO | F - Tax | $1.08 | -23.2K | 39.2K | -37% | -$25.1K |
| D | 2024-07-12 | 2024-06-24 | BIVI | KIM JOANNE WENDY | CFO | A - Grant | $0.00 | +73.0K | 112.2K | +186% | $0 |
| DI | 2024-03-06 | 2024-03-04 | BIVI | DO CUONG V | Pres, CEO, Dir | P - Purchase | — | +10.0K | 435.9K | +2% | — |
| 2023-12-13 | 2023-12-11 | BIVI | KIM JOANNE WENDY | CFO | A - Grant | $0.00 | +5,000 | 44.1K | +13% | $0 | |
| 2023-12-06 | 2023-11-09 | BIVI | ROGICH SIGMUND | Dir | A - Grant | $0.00 | +42.3K | 42.3K | New | $0 | |
| 2023-12-06 | 2023-11-09 | BIVI | Hariri Robert J | Dir | A - Grant | $0.00 | +42.3K | 42.3K | New | $0 | |
| 2023-12-06 | 2023-11-09 | BIVI | BERMAN RICHARD J | Dir | A - Grant | $0.00 | +51.8K | 69.2K | +298% | $0 | |
| 2023-12-06 | 2023-11-09 | BIVI | GORLIN STEVE | Dir | A - Grant | $0.00 | +46.4K | 122.0K | +61% | $0 | |
| 2023-12-06 | 2023-12-01 | BIVI | GORLIN STEVE | Dir | S - Sale | $1.69 | -75.7K | 46.4K | -62% | -$127.9K | |
| 2023-12-01 | 2023-11-30 | BIVI | DO CUONG V | Pres, CEO, Dir | P - Purchase | $1.78 | +10.0K | 68.8K | +17% | +$17.8K | |
| 2023-09-07 | 2023-09-05 | BIVI | GORLIN STEVE | Dir | S - Sale | $3.05 | -8,560 | 75.7K | -10% | -$26.1K | |
| 2023-08-24 | 2023-08-22 | BIVI | BERMAN RICHARD J | Dir | S - Sale | $3.50 | -10.8K | 16.8K | -39% | -$37.8K | |
| DI | 2023-07-03 | 2023-06-29 | BIVI | DO CUONG V | CEO, Pres, Dir | A - Grant | $0.00 | +149.5K | 425.9K | +54% | $0 |
| DI | 2023-06-26 | 2023-06-21 | BIVI | DO CUONG V | CEO, Pres, Dir | M - OptEx | — | +41.5K | 271.4K | +18% | — |
| M | 2023-06-15 | 2023-05-22+ | BIVI | BERMAN RICHARD J | Dir | S - Sale | $6.12 | -11.0K | 23.2K | -32% | -$67.3K |
| M | 2023-04-06 | 2023-03-27+ | BIVI | BERMAN RICHARD J | Dir | S - Sale | $8.52 | -11.0K | 34.2K | -24% | -$93.6K |
| 2023-02-22 | 2023-02-16 | BIVI | KIM JOANNE WENDY | CFO | F - Tax | $6.12 | -2,476 | 39.1K | -6% | -$15.2K | |
| 2023-02-22 | 2023-02-16 | BIVI | READING CHRISTOPHER | EVP Neuroscience R, D | F - Tax | $6.12 | -2,476 | 37.1K | -6% | -$15.2K | |
| I | 2023-02-22 | 2023-02-16 | BIVI | DO CUONG V | CEO, Pres, Dir | F - Tax | $6.12 | -4,953 | 229.9K | -2% | -$30.3K |
| 2023-02-22 | 2023-02-16 | BIVI | Palumbo Joseph M | Chief Medical Off | F - Tax | $6.12 | -2,476 | 37.1K | -6% | -$15.2K | |
| 2023-02-22 | 2023-02-16 | BIVI | MARKHAM PENELOPE | EVP Liver Cirrhosis R, D | F - Tax | $6.12 | -2,476 | 47.8K | -5% | -$15.2K | |
| 2023-02-22 | 2023-02-16 | BIVI | Ahlem Clarence N. | EVP Neuroscience Product Dev | F - Tax | $6.12 | -2,476 | 37.1K | -6% | -$15.2K | |
| I | 2023-01-18 | 2022-11-23 | BIVI | DO CUONG V | CEO, Pres, Dir | A - Grant | $0.00 | +79.2K | 234.8K | +51% | $0 |
| 2023-01-18 | 2022-11-23 | BIVI | KIM JOANNE WENDY | CFO | A - Grant | $0.00 | +39.6K | 41.6K | +1,981% | $0 | |
| 2023-01-18 | 2022-11-23 | BIVI | READING CHRISTOPHER | EVP Neuroscience R, D | A - Grant | $0.00 | +39.6K | 39.6K | New | $0 | |
| 2023-01-18 | 2022-11-23 | BIVI | BERMAN RICHARD J | Dir | A - Grant | $0.00 | +43.6K | 45.2K | +2,724% | $0 | |
| 2023-01-18 | 2022-11-23 | BIVI | GORLIN STEVE | Dir | A - Grant | $0.00 | +34.2K | 84.2K | +68% | $0 | |
| 2023-01-18 | 2022-11-23 | BIVI | Ahlem Clarence N. | EVP Neuroscience Product Dev | A - Grant | $0.00 | +39.6K | 39.6K | New | $0 | |
| 2023-01-18 | 2022-11-23 | BIVI | Lang James Paul | Dir | A - Grant | $0.00 | +43.6K | 68.6K | +174% | $0 | |
| 2023-01-18 | 2022-11-23 | BIVI | MARKHAM PENELOPE | EVP Liver Cirrhosis R, D | A - Grant | $0.00 | +39.6K | 50.3K | +371% | $0 | |
| 2023-01-18 | 2022-11-23 | BIVI | Hariri Robert J | Dir | A - Grant | $0.00 | +34.2K | 34.2K | New | $0 | |
| 2023-01-18 | 2022-11-23 | BIVI | Palumbo Joseph M | Chief Medical Off | A - Grant | $0.00 | +39.6K | 39.6K | New | $0 | |
| DMI | 2022-08-26 | 2019-06-24+ | BIVI | PEIZER TERREN S | Dir, 10% | A - Grant | $45.00 | +16.38M | 9.62M | New | +$736.96M |
| DM | 2022-08-26 | 2019-01-02+ | BIVI | PEIZER TERREN S | Dir, 10% | A - Grant | $0.00 | +3,200 | 4.26M | +0.1% | $0 |
| DI | 2022-08-26 | 2018-08-13 | BIVI | PEIZER TERREN S | Dir, 10% | C - Cnv Deriv | — | +1.60M | 1.60M | New | — |
| DI | 2022-08-26 | 2020-09-22 | BIVI | PEIZER TERREN S | Dir, 10% | M - OptEx | $0.00 | +1.55M | 11.17M | +16% | $0 |
| DI | 2022-08-16 | 2022-08-15 | BIVI | PEIZER TERREN S | Dir, 10% | A - Grant | $1.65 | +3.64M | 23.17M | +19% | +$6.00M |
| 2022-02-16 | 2022-02-02 | BIVI | Adams Jonathan M | EVP Liver Cirrhosis Programs | G - Gift | $0.00 | -1,000 | 48.6K | -2% | $0 | |
| 2022-01-25 | 2021-12-31 | BIVI | DO CUONG V | Pres, CEO, Dir | A - Grant | $0.00 | +21.7K | 58.8K | +59% | $0 | |
| 2021-12-09 | 2021-12-07 | BIVI | KIM JOANNE WENDY | CFO | P - Purchase | $5.40 | +2,000 | 2,000 | New | +$10.8K | |
| 2021-10-29 | 2021-06-16 | BIVI | Adams Jonathan M | EVP Liver Cirrhosis Programs | G - Gift | $0.00 | -10.0K | 49.6K | -17% | $0 | |
| D | 2021-09-29 | 2020-01-02 | BIVI | BERMAN RICHARD J | Dir | A - Grant | $0.00 | +1,600 | 1,600 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations